SK Chemicals receives FDA approval for SID710

Home > Business > Industry

print dictionary print

SK Chemicals receives FDA approval for SID710

SK Chemicals said Wednesday it has won approval from the U.S. Food and Drug Administration (FDA) to sell its patch-type Alzheimer’s drug in the United States.

SID710, the generic drug referencing Novartis AG’s Exelon Patch to treat dementia symptoms associated with Alzheimer’s disease, received the green light from the FDA.

The approval marked the first time a South Korean company has applied for FDA approval for an Alzheimer’s patch on its own and received it.


More in Industry

Eastar Jet's pilot union pushes for receivership of airline

ITC agrees to review its decision in Botox dispute

Hyundai Motor and union come to a wage freeze deal

Samsung Biologics signs supply deal with AstraZeneca

Tesla to increase battery cell purchases from suppliers including LG

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now